What is the best biomarker for diagnosis of rejection in heart transplantation?

Clinical Transplantation

Volumn 23, Issue 5, 2009, Pages 672-680

  Martinez Dolz L ^a   Almenar, L ^a   Reganon, E ^b   Vila, V ^b   Sanchez Soriano R ^a   Martinez Sales V ^b   Moro, J ^a   Aguero J ^a   Sanchez Lazaro I ^a   Salvador, A ^a  

^a Heart Failure and Transplant Unit   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Inflammation; Rejection; Transplantation

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; SIALIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

ADULT; ANGIOGRAPHY; BIOLOGICAL MARKERS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INFLAMMATION; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 70350150483     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01074.x     Document Type: Article

References (39)

1. Taylor DO, Edwards LB, Boucek MM. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report - 2005. J Heart Lung Transplant 2005, 24:945.
2. Eisen HJ, Hicks D, Kant JA. Diagnosis of post-transplant lymphoproliferative disorder by endomyocardial biopsy in a cardiac allograft recipient. J Heart Lung Transplant 1994, 13:241.
3. Nakhleh RE, Jones J, Goswitz JJ, Anderson EA, Titus J. Correlation of endomyocardial biopsy findings with autopsy findings in human cardiac allografts. J Heart Lung Transplant 1992, 11:479.
4. Vila V, Reganon E, Aznar J. A method to determine fibrinogen level of plasma. Haemostasis 1982, 12:60.
5. Reganon E, Vila V, Aznar J. Gelification of fibrinogen in plasma. A kinetic study by turbidity measurement. Haemostasis 1984, 14:170.
6. O'Connell JB, Costanzo-Nordin MR, Subramanian R, Robinson JA. Dilated cardiomyopathy: emerging role of endomyocardial biopsy. Curr Probl Cardiol 1986, 11:445.
7. Lorell B, Alderman EL, Mason JW. Cardiac sarcoidosis: diagnosis with endomyocardial biopsy and treatment with corticosteroids. Am J Cardiol 1978, 42:143.
8. Moidl R, Chevtchik O, Simon P. Noninvasive monitoring of peak filling rate with acoustic quantification echocardiography accurately detects acute cardiac allograft rejection. J Heart Lung Transplant 1999, 18:194.
9. Valantine HA, Yeoh TK, Gibbons R. Sensitivity and specificity of diastolic indexes for rejection surveillance: temporal correlation with endomyocardial biopsy. J Heart Lung Transplant 1991, 10:757.
10. StGoar FG, Gibbons R, Schnittger I, Valantine HA, Popp RL. Left ventricular diastolic function. Doppler echocardiographic changes soon after cardiac transplantation. Circulation 1990, 82:872.
11. Mankad S, Murali S, Kormos RL, Mandarino WA, Gorcsan J. Evaluation of the potential role of color-coded tissue doppler echocardiography in the detection of allograft rejection in heart transplant recipients. Am Heart J 1999, 138:721.
12. Graceffo MA, O'Rourke RA. Cardiac transplant rejection is associated with a decrease in the high-frequency components of the high-resolution, signal-averaged electrocardiogram. Am Heart J 1996, 132:820.
13. Bourge R, Eisen H, Hershberger R. Noninvasive rejection monitoring of cardiac transplants using high resolution intramyocardial electrograms: initial US multicenter experience. Pacing Clin Electrophysiol 1998, 21:2338.
14. Eisen HJ, Eisenberg S, Saffitz JE, Bolman RM, Sobel BE, Bergmann SR. Noninvasive diagnosis of cardiac transplant rejection using labeled lymphocytes. Circulation 1987, 75:868.
15. Hesse B, Mortensen SA, Folke M, Brodersen AK, Aldershvile J, Pettersson G. Ability of antimyosin scintigraphy monitoring to exclude acute rejection during the first year after heart transplantation. J Heart Lung Transplant 1995, 14:23.
16. Narula J, Acio ER, Narula N. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 2001, 7:1347.
17. Deng MC, Eisen HJ, Mehra MR. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006, 6:150.
18. Mehra MR. The emergence of genomic and proteomic biomarkers in heart transplantation. J Heart Lung Transplant 2005, 24:S213.
19. Sakai T, Latson TW, Whitten CW. Perioperative measurements of interleukin-6 and alpha-melanocyte-stimulating hormone in cardiac transplant patients. J Cardiothorac Vasc Anesth 1993, 7:17.
20. Kimball P, Radovancevic B, Isom T, Frazier B, Kerman R. Cytokine panel predicts early rejection and therapeutic response after cardiac transplantation. Transplant Proc 1995, 27:1286.
21. Pearson TA, Mensah GA, Alexander RW. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499.
22. Eisenberg MS, Chen HJ, Warshofsky MK. Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients. Circulation 2000, 102:2100.
23. Labarrere CA, Lee JB, Nelson DR, Al-Hassani M, Miller SJ, Pitts DE. C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study. Lancet 2002, 360:1462.
24. Arora S, Gullestad L, Wergeland R. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation. Transplantation 2007, 83:1308.
25. Ferro D, Parrotto S, Basili S, Alessandri C, Violi F. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia. J Am Coll Cardiol 2000, 36:427.
26. Rosenson RS, Tangney CC, Casey LC. Inhibition of proinflammatory cytokine production by pravastatin. Lancet 1999, 353:983.
27. Kleemann R, Verschuren L, de Rooij BJ. Evidence for anti-inflammatory activity of statins and PPAR-alpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro. Blood 2004, 103:4188.
28. Okada M, Kitahara M, Kishimoto S, Matsuda T, Hirano T, Kishimoto T. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. J Immunol 1988, 141:1543.
29. Wolvekamp MC, Marquet RL. Interleukin-6: historical background, genetics and biological significance. Immunol Lett 1990, 24:1.
30. Liang Y, Christopher K, Finn PW, Colson YL, Perkins DL. Graft produced interleukin-6 functions as a danger signal and promotes rejection after transplantation. Transplantation 2007, 84:771.
31. Jordan SC, Czer L, Toyoda M. Serum cytokine levels in heart allograft recipients: correlation with findings on endomyocardial biopsy. J Heart Lung Transplant 1993, 12:333.
32. Chollet-Martin S, Depoix JP, Hvass U, Pansard Y, Vissuzaine C, Gougerot-Pocidalo MA. Raised plasma levels of tumor necrosis factor in heart allograft rejection. Transplant Proc 1990, 22:283.
33. Arbustini E, Grasso M, Diegoli M, Bramerio M, Foglieni AS, Albertario M. Expression of tumor necrosis factor in human acute cardiac rejection. An immunohistochemical and immunoblotting study. Am J Pathol 1991, 139:709.
34. Abdallah AN, Billes MA, Attia Y, Doutremepuich C, Cassaigne A, Iron A. Evaluation of plasma levels of tumour necrosis factor alpha and interleukin-6 as rejection markers in a cohort of 142 heart-grafted patients followed by endomyocardial biopsy. Eur Heart J 1997, 18:1024.
35. Collins T, Lapierre LA, Fiers W, Strominger JL, Pober JS. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc Natl Acad Sci USA 1986, 83:446.
36. Pujo-Borrell R, Hanafusa T, Chiovato L, Bottazzo GF. Lectin-induced expression of DR antigen on human cultured follicular thyroid cells. Nature 1983, 304:71.
37. Bakri RS, Afzali B, Covic A. Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation. Clin Transplant 2004, 18:201.
38. Turner DM, Grant SCD, Lamb WR. A genetic marker of high TNF-a production in heart transplant recipients. Transplantation 1995, 60:1113.
39. Abdallah AN, Cucchi-Mouillot P, Biteau N, Cassaigne A, Haras D, Iron A. Analysis of the polymorphism of the tumour necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering or not suffering from severe rejection. Eur J Immunogenet 1999, 26:249.